Melanocyte Stem Cell Maintenance and Hair Graying  by Steingrímsson, Eiríkur et al.
Cell, Vol. 121, 9–12, April 8, 2005, Copyright ©2005 by Elsevier Inc. DOI 10.1016/j.cell.2005.03.021
MinireviewMelanocyte Stem Cell Maintenance
and Hair GrayingEiríkur Steingrímsson,1 Neal G. Copeland,2
and Nancy A. Jenkins2,*
1Department of Biochemistry and Molecular Biology
Faculty of Medicine
University of Iceland
Vatnsmyrarvegur 16
101 Reykjavik
Iceland
2Mouse Cancer Genetics Program
Center for Cancer Research
National Cancer Institute
Frederick, Maryland 21702
Hair graying is an obvious sign of human aging, yet
little was known about its causes. Two recent papers
provide compelling evidence that hair graying is due
to incomplete melanocyte stem cell maintenance and
identify Pax3 and Mitf as key molecules that help reg-
ulate the balance between melanocyte stem cell main-
tenance and differentiation.
The neural crest origin of pigment-producing melano-
cytes has been carefully traced and documented. Mela-
noblasts, the precursors to melanocytes, originate in
the neural crest and travel to their destinations, includ-
ing the hair follicle, where they differentiate into mela-
nocytes that produce the pigment melanin. In the hair
follicle, the life of a melanocyte is tightly integrated with
the cyclical nature of the follicle. The hair follicle cycle
consists of a finite period of hair fiber production and
growth (anagen), followed by a brief regression period
(catagen) and a resting period of little activity (telogen).
In mice and most other mammals, the anagen growth
phase occurs in a wave-like pattern across the skin sur-
face, whereas, in humans, each follicle cycles indepen-
dently of its neighbors. The activity of melanocytes in
the hair matrix is also under cyclical control where me-
lanogenesis and anagen are tightly coupled; melano-
cytes in the hair bulb are terminally differentiated and
die in early catagen by an unknown mechanism.
Hair follicles are known to contain a reservoir of epi-
thelial stem cells in the bulge region (Figure 1), which
can regenerate new follicles upon each hair cycle
(Blanpain et al., 2004). The existence of a pool of undif-
ferentiated melanocyte stem cells (MSCs) in the hair
that can also replenish the pool of differentiated mela-
nocytes has long been suspected. Nishimura et al.
(2002) used a simple yet clever technique that made it
possible to identify and localize MSCs in the hair folli-
cle. In these studies, Dct-LacZ transgenic mice were
used as a marker for early melanoblast development
(Mackenzie et al., 1997); Dct (sometimes referred to as
Trp2) codes for dopachrome tautomerase. In addition,
an anti-Kit antibody was used to selectively deplete
amplifying melanoblasts from neonatal mice, while at
the same time leaving resting cells intact (Nishikawa et
al., 1991; Okura et al., 1995). When newborn mice were*Correspondence: jenkins@ncifcrf.govinjected subcutaneously with the anti-Kit antibody, they
had unpigmented first hairs. In subsequent hair cycles,
however, pigmentation was restored in the developing
dorsal overhairs and ventral sensory hairs (Nishimura
et al., 2002). This suggested that the hair follicle con-
tains a Kit-independent (resting) melanocyte precursor
population that can restore pigment to the hair in later
hair cycles. In antibody-treated Dct-LacZ transgenic
mice, LacZ-positive cells were seen in the bulge area
(Figure 1A) and sometimes also in the subbulge region
of the hair follicles. This is consistent with previous an-
tibody staining experiments, which documented the
existence of “amelanotic melanocytes” within human
hair follicles (Commo and Bernard, 2000) and with more
recent studies showing that Dct-positive cells are pre-
sent in the bulge region of the mouse hair follicle
(Botchkareva et al., 2003). These LacZ-positive cells
are the ones most likely to produce mature melano-
cytes, since, during subsequent hair cycles, pigmented
cells were only found in the hair matrix of cells whose
bulge area retained LacZ-positive cells (Nishimura et
al., 2002). This raised the interesting possibility that
LacZ-positive cells in the bulge area are MSCs, capable
of both self renewal and differentiation into fully fledged
pigmented melanocytes.
The LacZ-positive cells have a low proliferation rate,
consistent with stem cell properties. To investigate the
regenerative potential of these cells, vibrissal hair folli-
cles from Rosa26 mice, which express LacZ in all tis-
sues, were divided into three fragments and each frag-
ment implanted into the skin of newborn albino pups.
This experiment clearly demonstrated the existence of
MSCs in the lower portion of the hair follicle and
showed that there are Dct-positive melanoblasts in the
bulge. Although this confirms the presence of MSCs
in the bulge area, it is not yet clear if Dct-positive or
-negative MSCs also exist outside the bulge area in the
hair follicle.
The LacZ-positive cells in the bulge area are small
and oval shaped and are considered immature since
they do not contain melanin; this is considered the dor-
mant state of the cells. As the hair cycle progresses
from telogen to anagen, expression of LacZ, as well as
the size of the cells, increases. Subsequently, the cells
divide, and at least one LacZ-positive cell remains in
the bulge while others extend their processes toward
the follicular papillae and eventually localize to the hair
matrix where they undergo further cell divisions and
differentiate into pigment-producing cells. Thus, the
LacZ-positive cells in the bulge region have all the hall-
marks of stem cells; they are slow cycling, self maintain-
ing, and able to generate differentiated pigment cells.
The bulge region also has the properties expected
for a MSC niche. In mice, melanocytes are generally
confined to the hair follicles in the epidermis (with the
exception of ears, footpads, and tail), whereas, in hu-
mans, they are dispersed among epidermal keratino-
cytes. When Kitl, the ligand for Kit, is expressed in the
skin of transgenic mice under the control of the kerati-
nocyte K14 promoter, the mice develop pigmented
skin, much like human skin (Kunisada et al., 1998). By
making mice that carry both the K14-Kitl and Dct-LacZ
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10Figure 1. The Melanocyte Stem Cell during
the Hair Cycle
(A) Several stages of the hair cycle are
shown, with the MSCs (purple), amplifying
cells (red), and melanocytes (green) indi-
cated. Modified from Nishimura et al. (2002).
(B) The MSCs in the bulge area divide to pro-
duce daughter cells that self renew (purple)
and cells that differentiate (red).transgenes and then using the anti-Kit antibody to de- J
mplete amplifying melanoblasts from neonates, Nishi-
mura et al. (2002) showed that, as expected, LacZ-posi- c
gtive cells are exclusively maintained in the bulge area
during the first hair cycle when Kitl is ectopically ex- (
mpressed in the skin. In the next hair cycle, however,
many follicles had no functional melanoblasts, suggest- M
oing vacant niches and that not all the MSCs are Kit in-
dependent. The follicles that did contain functional t
omelanocytes produced pigmented hair and were able
to drive repigmentation of the epidermis. LacZ-positive m
cmelanoblasts were observed in the bulge region as well
as the surrounding epidermis during the repigmentation e
wprocess. This indicates that bulge MSCs are a source
of melanocytes in the epidermis and that Kitl expres- m
dsion in the epidermis provides a migration route for the
differentiating melanoblasts. Some of the migrating t
mmelanoblasts were also seen to repopulate empty niches
where they returned to a quiescent state with small a
nround cells, eventually generating more melanocytes.
The melanocyte niche therefore seems to have the abil- w
Lity to attract more MSCs, similar to the homing mecha-
nism described for hematopoietic stem cells (Whetton e
gand Graham, 1999). Interestingly, Tumbar et al. (2004)
have shown that bulge epidermal cells express high f
levels of Kitl, which may help in the recruitment of
MSCs to their niche. In summary, MSCs reside in the t
nniche and can produce transiently amplifying cells,
which can differentiate into melanocytes or migrate into l
tempty niches and return to a stem cell fate. Currently,
it is not known whether the MSCs are restricted in po- c
Stential and can only give rise to melanocytes or whether
they are multipotent and able to produce other cell i
htypes as well.
Along with David Fisher, Nishimura set out to exam- s
rine the relationship between MSC maintenance and
hair graying. Previous investigators had proposed that t
2the oxidative nature of melanin biosynthesis is cyto-
toxic, leading to the degeneration of pigmented mela- t
onocytes over time and to hair graying (Johnson andackson, 1992; Veis et al., 1993). However, Fisher, Nishi-
ura, and their colleagues show that this is not the
ase and instead provide compelling evidence that hair
raying results from incomplete MSC maintenance
Nishimura et al., 2005). Using the Dct-LacZ transgenic
ice, Nishimura and associates mapped the fate of
SCs in Bcl2 and Mitf mutant mice, two mouse models
f hair graying. Mice carrying a knockout mutation in
he antiapoptotic Bcl2 gene turn gray during the sec-
nd hair follicle cycle, suggesting that Bcl2 protects
elanocytes from apoptosis (Veis et al., 1993). Melano-
yte distribution and morphology are normal during
arly embryonic development in these mice, consistent
ith the initial normal phenotype of Bcl2−/− mice (Nishi-
ura et al., 2005). However, in 39-day-old Bcl2−/− mice,
ifferentiated melanocytes are nearly absent from both
he body and whisker hair follicles. The follicles are
issing differentiated melanocytes from the hair bulb
s well as undifferentiated Dct-LacZ-positive mela-
oblasts from the bulge area. Bcl2+/− heterozygote and
ild-type controls have normal pigmentation, and Dct-
acZ-positive cells are present in both cases. The same
ffect was observed in Bcl2−/− mice on the albino back-
round, showing that melanin pigment is not necessary
or melanocyte loss in these mice.
Both differentiated melanocytes and Dct-LacZ-posi-
ive cells in the bulge area were present and appeared
ormal in 6.5-day-old Bcl2−/− mice. However, 2 days
ater, nearly all Dct-LacZ-positive cells were gone from
he bulge area, whereas differentiated melanocytes
ould still be seen in the hair bulb in normal numbers.
taining with Kit antibodies showed that, at this stage
n wild-type mice and then cyclically during subsequent
air cycles, the bulge MSCs change from dendritic to a
lender, oval shape, and their nuclear-to-cytoplasmic
atio increases. This represents the dormant state of
he MSCs (Nishimura et al., 2002; Nishimura et al.,
005). TUNEL staining of MSCs in Bcl2−/− mice showed
hat these cells undergo apoptosis at this critical stage
f melanocyte development. Thus, Bcl2 appears to be
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11necessary for protecting the MSCs from succumbing to
apoptosis during entry into the dormant state.
Another model of hair graying is provided by the viti-
ligo (Mitf vit) mutation in the melanocyte master tran-
scriptional regulator Mitf. Homozygous Mitf vit mice are
born pigmented with dorsal and ventral white spots
and then develop progressive depigmentation of pig-
mented hair with each hair cycle or after plucking (see
Steingrímsson et al. [2004]). MSCs are initially present
in these mutant mice but are gradually lost with each
hair cycle. Paradoxically, the LacZ-positive cells left in
the niche of third hair cycle follicles of Mitf vit/vit mice
often contain melanin pigment and show dendritic mor-
phology, a sign of differentiation. These cells are not
found in age-matched controls, suggesting that they
represent MSCs that have differentiated prematurely
while residing in the niche or have lost the ability to
migrate to their destination in the matrix.
Hair graying is also observed in mice during normal
aging. When the fate of LacZ-positive niche stem cells
was traced during normal aging in Dct-LacZ transgenic
mice, they were seen to be gradually lost with age (Nis-
himura et al., 2005). Furthermore, pigmented melano-
cytes were found in the niche of 8-month-old wild-type
follicles, just like in Mitf vit/Mitf vit mice. The appearance
of the pigmented cells in the niche happened as the
LacZ-positive cells disappeared and both processes
correlated with aging. Moreover, by staining human hair
follicles with antibodies to the MSC marker Mitf, Nishi-
mura et al. (2005) showed the existence of Mitf-positive
cells in the bulge area of human hairs, similar to what
was observed in mice. “Amelanotic melanocytes” had
been previously observed in human follicles using an-
other melanocyte marker, pMel17 (Commo and Ber-
nard, 2000). The Mitf-positive cells were numerous in
20- to 30-year-olds, whereas they were absent in 70- to
90-year-olds. Remarkably, in 40- to 60-year-old individ-
uals, just like in Mitf vit/Mitf vit and normal aging mice,
pigmented Mitf-positive cells were observed in the
bulge area. This suggests that hair graying involves a
failure in MSC maintenance, resulting in the gradual
loss of pigmented progeny upon aging. Furthermore,
the MSCs seem to differentiate prematurely within the
niche, a process enhanced by the Mitf vit mutation.
Thus, Mitf may be important for MSC self renewal. Mitf
has been shown to regulate Bcl2 expression (McGill et
al., 2002). Since the effect of the Mitf vit mutation on
stem cell fate is less severe than the Bcl2 mutation, the
Mitf vit mutation might not eliminate Bcl2 expression,
and other transcriptional targets might be involved in
the resulting phenotype.
What, then, are the genes that control MSC mainte-
nance and hair graying? In a recent paper, Jonathan
Epstein and colleagues show that the transcription
factor Pax3 is critically important for MSC maintenance
(Lang et al., 2005). The PAX3 gene is mutated in a sub-
group of patients with Waardenburg Syndrome, a pig-
mentary and deafness disorder. Mutations in the MITF
and SOX10 genes also result in Waardenburg Syn-
drome, and several studies have shown that the PAX3
and SOX10 proteins regulate MITF expression (re-
viewed in Steingrímsson et al. [2004]). Lang and associ-
ates now show that Pax3 is expressed in MSCs in the
bulge region where its expression overlaps Dct-LacZ
transgene expression in most cases. Dct-LacZ-express-
ing cells are neural crest derived and express Mitf and
Sox10 in addition to Pax3. Transfection studies in 293Tcells showed that Sox10 and Mitf activate the Dct en-
hancer synergistically, whereas Pax3 represses Mitf/
Sox10-mediated activation of Dct. Binding sites for all
three transcription factors are present in the Dct en-
hancer, and chromatin immunoprecipitation studies
showed that all three proteins are able to bind this en-
hancer region. In parallel studies using identical condi-
tions, Lang et al. (2005) showed that Pax3 activates Mitf
expression, while, at the same concentration, it re-
presses expression from the Dct enhancer. Pax3 binds
the enhancer with low affinity. Interestingly, however,
chromatin immunoprecipitation studies using different
ratios of the Pax3 and Mitf proteins showed that Pax3
binding is preferred when the proteins are at equal ra-
tios, whereas Pax3 is displaced from the enhancer at
higher concentrations of Mitf. Thus, Pax3 seems to act
as a competitive inhibitor of Mitf on the Dct enhancer.
In addition to Pax3 and Mitf, β-catenin and its in-
teracting transcription factor Tcf/Lef, as well as the
Groucho-related corepressor Grg4, also seem to be in-
volved in this process. A binding site for the Lef/Tcf
transcription factor is located immediately adjacent to
the Mitf binding site in the Dct enhancer (Lang et al.,
2005). By cotransfecting activated β-catenin, a cofactor
for Tcf/Lef proteins, Pax3-mediated repression was re-
lieved and the Pax3 protein displaced from the Dct en-
hancer. Pax3 also interacts with Grg4 on the Dct en-
hancer. Activated β-catenin removes Grg4 from the Dct
enhancer, resulting in the loss of Pax3-mediated re-
pression. This suggests that β-catenin causes the rea-
lignment of the protein complex at the Dct enhancer.
Consistent with this, immunoprecipitation studies showed
that Lef1, Pax3, and Grg4 form a complex in solution,
and, when activated β-catenin is added, the Pax3 and
Grg4 proteins can no longer complex with Lef1. Further
support for this complex formation comes from studies
on mouse B16 melanoma cells. Upon transfection of a
dominant-negative Lef1 protein into these cells, Pax3,
which is not normally located at the Dct enhancer in
these cells, and Grg4 bind to the enhancer and repress
Dct expression. Interestingly, by creating mouse em-
bryos that lacked β-catenin in Pax3-expressing cells,
Lang and associates were able to show that Dct was
no longer expressed in the skin, while Mitf- and Pax3-
expressing cells could still be found. Thus, β-catenin is
required in Pax3-expressing melanocyte precursors for
the proper induction of Dct expression.
The model of Lang and associates proposes that
Pax3 and Sox10 activate Mitf expression while, at the
same time, Pax3 inhibits Mitf from activating down-
stream genes (Lang et al., 2005). Thus, the Mitf protein
accumulates and is ready to rapidly activate down-
stream genes as soon as Pax3-mediated repression is
lifted upon β-catenin signaling. This is an interesting
model with implications for stem cells in general. How-
ever, the interactions are probably not as simple as pro-
posed. First, the three pigmentation enzymes Dct,
Tyrp1, and tyrosinase (all Mitf targets) are expressed
in a temporally regulated manner, suggesting that the
cellular environment may have a major effect. While ex-
pression of Dct is increased during anagen (Nishimura
et al., 2005), it is expressed in MSCs before they dif-
ferentiate into pigment-producing cells, as evidenced
by in situ hybridization (Nishimura et al., 2002), im-
munostaining (Lang et al., 2005), and Dct-LacZ trans-
genic expression (Nishimura et al., 2002). Detailed ex-
pression analysis of Dct, Tyrp1, and tyrosinase proteins
Cell
12during hair follicle morphogenesis in C57BL/6 mice c
shows that Dct is expressed in early hair follicles and d
stays on in the differentiating melanocytes as well as in m
nonproliferating cells in the bulge area (Botchkareva et a
al., 2003). Tyrp1 protein expression comes on later as n
the cells near the dermal papilla; melanin synthesis be-
comes apparent as the cells become tyrosinase posi- m
tive (Botchkareva et al., 2003). Tyrp1 gene expression t
is itself regulated by Pax3 (Galibert et al., 1999). Sec-
ond, the premature pigmentation seen in niche MSCs in
AMitf vit/Mitf vit mice is also not consistent with the model,
since, according to the model, reduced function of Mitf
Wshould lead to reduced pigmentation. Rather, the pre-
mmature pigmentation of MSCs suggests that Mitf might
play a role in MSC self renewal and may itself provide a
nodal point in the process of deciding whether to main-
Stain an undifferentiated state or to differentiate. This may
initiate with a decision of whether to enter or exit the “dor-
B
mant state” in the niche, and, ultimately, this decision may (
be directly related to cell cycle decisions.
B
Interestingly, several laboratories have recently shown I
that Mitf regulates the expression of genes involved in
Ccontrolling cell cycle exit. Loercher et al. (2005) showed
D
that Mitf activates the expression of p16Ink4a resulting
Cin cell cycle arrest and reduced phosporylation of the
FRb protein. They also showed that Mitf-mediated cell
Gcycle arrest and differentiation are interconnected pro-
Bcesses. Using mouse embryonic fibroblasts from wild-
Jtype and Ink4a homozygous mutant mice, they showed
Kthat transfecting Mitf-expressing constructs into these
Hcells induces cell cycle arrest in wild-type cells but not
(in mutant cells. Similarly, when assessed for morpho-
Llogic changes, the Mitf-transfected cells showed a
Lmorphology consistent with melanocyte differentiation,
4whereas Ink4a mutant cells did not, suggesting that
Lp16Ink4a is necessary for the Mitf-mediated differentia-
Jtion program. In another recent paper, Carreira et al.
M(2005) showed that Mitf regulates the expression of
Dp21Cip1, inducing cell cycle arrest; the arrest does not
Mtake place in p21Cip1-deficient cells. While they point
Nout that mice lacking p21Cip1 have normal pigmenta-
ation, as do mice lacking Ink4a, it is possible that a cer-
Ntain degree of redundancy is built into the system, with
SMitf activating both p21Cip1 and p16Ink4a to guarantee
2cell cycle exit. Carreira and associates propose that
NMitf acts to integrate different extracellular signals with
Mcell division and differentiation and propose a model
k
involving a positive feedback loop.
NSimilar mechanisms might also be at work to regulate
7
MSC fate in the niche. During the hair cycle, quiescent
OMSCs in bulge regions of hair follicles are likely to re-
Iceive signals instructing entry into the cell cycle. One of
Sthe resulting daughter cells may partially exit the niche
Rmicroenvironment and thereby receive additional differ-
Tentiation signals (Figure 1B), while the daughter cell re-
Mmaining in the niche is instructed to exit the cell cycle
Vand at the same time is protected from apoptosis. Mitf
(is known to regulate all of these processes, and, since
Wmultiple different signaling mechanisms can affect the
expression, transcriptional activity, or stability of the
Mitf protein (reviewed in Steingrímsson et al. [2004]), it
is entirely possible that the different signals received by
the daughter cell are translated into different effects on
Mitf activity, with subsequent effects on transcription
regulation. Although the exact signals involved in each
case are not known at present, Okura et al. (1995) have
shown that Kit mediates a survival signal in melano-ytes. In support of this, Kitl is expressed in bulge epi-
ermal cells (Tumbar et al., 2004). Additional signals
ay include β-catenin as well as other signaling mech-
nisms known to be important in the bulge stem cell
iche (Fuchs et al., 2004).
In summary, melanocytes and pigment mutations in the
ouse have yet again proven their worth for dissecting
he inner workings of complex eukaryotic cell processes.
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